Urology · Santa Maria, CA
NPI
1962664409
Since 2008
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
116 S Palisade Dr Ste 110
Santa Maria, CA, 93454
Phone (805) 349-7133
Groups this clinician bills Medicare through
Medicare paid, 2024
$940K
38,547 services
Medicare patients, 2024
2,373
Average age 76
Drug cost, 2024
$2.8M
6,358 prescriptions
Company payments, 2025
$2,254
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brett D Lebed was code J0585 (injection, onabotulinumtoxina, 1 unit), 13,800 times for 72 patients. In total Brett D Lebed billed 38,547 services in 125 codes, and Medicare paid $940K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 13,800 | 72 | $4.88 | $67K |
| J0897 Injection, denosumab, 1 mg | Office | 4,320 | 18 | $20.81 | $90K |
| 99214 Office E&M - Established | Office | 2,282 | 1,643 | $95.25 | $217K |
| 81003 Clinical Chemistry | Office | 2,136 | 1,567 | $2.20 | $4,690 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,141 | 932 | $11.91 | $14K |
| 51798 Ultrasound - Nonspecific | Office | 998 | 851 | $9.16 | $9,139 |
| 99213 Office E&M - Established | Office | 932 | 741 | $69.25 | $65K |
| 99459 Office/Outpatient Services | Office | 594 | 467 | $18.54 | $11K |
| 99204 Office E&M - New | Office | 386 | 386 | $118.90 | $46K |
| 52000 Cystourethroscopy | Office | 321 | 268 | $190.72 | $61K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 223 | 32 | $136.32 | $30K |
| 99212 Office E&M - Established | Office | 188 | 164 | $44.35 | $8,337 |
| 51701 Other Organ Systems | Office | 108 | 91 | $35.11 | $3,792 |
| 52287 Cystourethroscopy | Office | 108 | 72 | $330.79 | $36K |
| 74420 Standard X-ray | Facility | 92 | 66 | $18.44 | $1,697 |
By year: 2022 $927K for 38,385 services; 2023 $918K for 29,653 services; 2024 $940K for 38,547 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 2,136 | 1,567 | $2.20 | $4,690 |
Medicare prescription drug claims, 2024
In 2024, the drug Brett D Lebed prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,287 prescriptions and refills. In total Brett D Lebed wrote 6,358 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,287 | 3,665 | 419 | $26K |
| Finasteride Generic | 1,233 | 3,543 | 383 | $20K |
| Myrbetriq Mirabegron | 619 | 1,456 | 218 | $643K |
| Estradiol Generic | 577 | 2,159 | 354 | $38K |
| Solifenacin Succinate Generic | 326 | 879 | 115 | $21K |
| Gemtesa Vibegron | 300 | 783 | 112 | $368K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 223 | 655 | 89 | $8,643 |
| Methenamine Hippurate Generic | 164 | 414 | 66 | $17K |
| Potassium Citrate Er Potassium Citrate | 115 | 246 | 35 | $12K |
| Tolterodine Tartrate Er Tolterodine Tartrate | 114 | 279 | 34 | $10K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 90 | 90 | 73 | $1,188 |
| Xtandi Enzalutamide | 85 | 85 | Under 11 | $1.2M |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 82 | 82 | 72 | $378 |
| Tramadol Hcl Generic | 74 | 74 | 71 | $110 |
| Levofloxacin Generic | 70 | 70 | 62 | $142 |
Brand drugs: 1,139 claims; generic drugs: 5,198 claims; opioid claims: 170.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brett D Lebed $2,254 ($2,254 in general payments such as food, travel and fees) from 24 companies. The largest payer was Abbvie Inc. with $290.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 14 | $290 |
| Immunitybio, Inc. IBRX | 2 | $186 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $163 |
| Bluewind Medical | 8 | $156 |
| Progenics Pharmaceuticals, Inc. | 2 | $151 |
| Janssen Biotech, Inc. JNJ | 7 | $138 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $128 |
| Pfizer Inc. PFE | 5 | $119 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $118 |
| Procept Biorobotics Corporation PRCT | 1 | $118 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.